John Hohneker
Board Member
ArriVent BioPharma, Inc. (AVBP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John Hohneker
John Hohneker is recorded as Board Member at ArriVent BioPharma, Inc. (AVBP). Carisma Therapeutics Inc. reported in an 8-K filed October 15, 2025 that John Hohneker resigned as director, effective October 15, 2025.
“On October 14, 2025, each of John Hohneker, M.D., Briggs Morrison, M.D. and David Scadden M.D. notified the Company of such director's decision to resign from the Company's board of directors (the "Board") and all committees thereof, effective October 15, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ArriVent BioPharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Winston Kung CFO
- Robin LaChapelle COO
- James Kastenmayer General Counsel
- Chris W. Nolet Board Member
- James Healy Board Member
- John Hohneker, M.D. Board Member
- Kristine Peterson Board Member
- Merdad Parsey Board Member
- Merdad Parsey, M.D., Ph.D. Board Member
- Stuart Lutzker Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.